Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Inventory (2019 - 2025)

Quantum Biopharma's Inventory history spans 3 years, with the latest figure at $52133.0 for Q4 2025.

  • On a quarterly basis, Inventory fell 55.53% to $52133.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $52133.0, a 55.53% decrease, with the full-year FY2025 number at $52133.0, down 55.53% from a year prior.
  • Inventory hit $52133.0 in Q4 2025 for Quantum Biopharma, down from $117242.0 in the prior quarter.
  • Over the last five years, Inventory for QNTM hit a ceiling of $117242.0 in Q4 2024 and a floor of $52133.0 in Q4 2025.